ATG5 and Hepatic fibrosis: Blocking autophagy in hematopoietic stem cells using 3-methyladenine, doxazosin or specific siRNA targeting ATG5 and ATG7 resulted in reduced activation of HSCs and attenuation of liver fibrosis (32, 33).